Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL28856904

CN1CCN([C@@H]2CCCNC2)C1=O.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.37
▸ BTK Q06187 3/20 0.35
▸ LCK P06239 2/20 0.35
▸ JAK3 P52333 2/20 0.35
▸ EGFR P00533 1/20 0.35
▸ SLC6A1 P30531 2/20 0.33
▸ SLC6A11 P48066 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SLC6A13 Q9NSD5 1/20 0.33
▸ IRAK4 Q9NWZ3 2/20 0.33
▸ F10 P00742 2/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ PDE7A Q13946 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ NPY5R Q15761 1/20 0.32
▸ F2 P00734 1/20 0.32
▸ PDE9A O76083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16763877 0.88 PARP1 (0.38) PARP1LCKJAK3EGFRHTR2C
SCHEMBL16763874 0.88 PARP1 (0.38) PARP1LCKJAK3EGFRHTR2C
Hydrochloric Acid SCHEMBL21855144 0.86 PARP1 (0.37) PARP1LCKJAK3EGFRHTR2C
SCHEMBL20986376 0.81 HTR2C (0.39) PARP1NPY5RHTR2CHTR2B
SCHEMBL20986373 0.81 HTR2C (0.39) PARP1NPY5RHTR2CHTR2B
SCHEMBL16786083 0.81 HTR2C (0.39) PARP1NPY5RHTR2CHTR2B
Hydrochloric Acid SCHEMBL16764419 0.79 HTR2C (0.39) PARP1NPY5RHTR2CHTR2B
Hydrochloric Acid SCHEMBL16764417 0.79 HTR2C (0.39) PARP1NPY5RHTR2CHTR2B
Trifluoroacetic Acid SCHEMBL31613316 0.78 PARP1 (0.37) PARP1SLC6A1SLC6A11TSHRLMNA
SCHEMBL27175872 0.75 PARP1 (0.36) PARP1PIM1PIM2HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003304-A Bifunctional compounds for the degradation of BTK via the ubiquitin proteasome pathway 纽力克斯治疗公司 2022-09-02 — — CN disclosed
Send feedback